BBR Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

BBR Partners’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$37K	–	272
2025 Q1	$37K	Hold	100,000	–	–	﹤0.01%	241
2024 Q4	$71.4K	Hold	100,000	–	–	0.01%	241
2024 Q3	$112K	Buy	+100,000	New	+$112K	0.01%	229

Other funds holding ENZ

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

BBR Partners's ENZ Position: Q2 2025 in Review

BBR Partners sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 100,000 shares — an estimated $37K sold.

BBR Partners first reported a position in ENZ in Q3 2024 and held it in 3 quarters. The position peaked at $112K in Q3 2024. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

BBR Partners reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
BBR Partners sold 100,000 Enzo Biochem, Inc. shares in Q2 2025, an estimated $37K.
BBR Partners first reported a position in Enzo Biochem, Inc. in Q3 2024 and held it in 3 quarters.
BBR Partners's Enzo Biochem, Inc. position peaked at $112K in Q3 2024.
6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on BBR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.